

NEOMAX-625 Amoxicillin Potassium Clavulanate & Lactic Acid Bacillus Tablets (625 mg, 10 Tablets)
₹ 1,300/Box
| Packaging Size | 10 Tablets |
| Strength | 625 mg |
| Pack Size | 10 tablets |
| Usage | Human |
| Brand | NEOMAX-625 |
| Packaging Type | Stripe |
| Prescription | Prescription |
| Brand Name | Amoxyclav |
| Manufacturer | JM LABORATORIES |
| Form | Tablet |
| Shelf Life | 18 months |
| Treatment | Respiratory Infection, Diarrhoea Prevention, ENT Infection, Bacterial Infection |
| Composition | Clavulanate, Amoxicillin, Lactic Acid Bacillus |
| Country of Origin | Made in India |
| Availability | In Stock |
| View in Hindi | निओमैक्स-625 एमोक्सिसिलिन पोटेशियम क्लैवुलनेट और लैक्टिक एसिड बैसिलस टैबलेट (625 mg, 10 टैबलेट) |
Find related categories
Shipping Information
| Price | Excluding all taxes |
| Shipping | As per delivery location |
Product Image




About the Company
- GST Registration Date
- Jul 2017
- Legal Status of Firm
- Limited Company
- Nature of Business
- Trader - Wholesaler/Distributor
- Number of Employees
- 26 To 50 People
- Annual Turnover
- 25 - 100 Cr
- IndiaMART Member Since
- Jan 2011
- GST
- 04**********1ZQ
Incorporated in the year 2006, in Chandigarh (India), we “J. M. Healthcare (P) LTD.”, are the distinguished manufacturer and supplier of optimum grade Pharmaceutical Capsules, Pharmaceutical Tablets, Pharmaceutical Syrup, Pharmaceutical Power, Pharmaceutical Injections, etc. Our offered medicines are processed using active agents and modular processing machines under the visionary guidance of trained professionals. These medicines are widely medicated for treatment of different types of problems like infection allergy, asthma, diabetes, cancer, etc. Our offered medicines are made available in a gradation of packaging options, in order to facilitate safer deliveries. These medicines are widely demanded and recommended by doctors due to their enormous features like accurate composition, quick result, effectiveness, safe to consume, hygienically packed, long shelf life and purity.







